Cell biology of hepatocarcinogenesis.
Saeter
G
G
Department of Tissue Culture, Norwegian Radium Hospital, Oslo.
Seglen
P O
PO
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002273:Carcinogens / Q000633:toxicity; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000473:pathology*; D002455:Cell Division; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced / Q000187:drug effects / Q000235:genetics; D056486:Chemical and Drug Induced Liver Injury; D002796:Choline Deficiency / Q000150:complications; D003043:Cocarcinogenesis; D004249:DNA Damage; D004351:Drug Resistance; D004357:Drug Synergism; D005786:Gene Expression Regulation / Q000187:drug effects; D012739:Gonadal Steroid Hormones / Q000633:toxicity; D006133:Growth Substances / Q000235:genetics / Q000502:physiology; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000473:pathology; D008113:Liver Neoplasms / Q000235:genetics / Q000473:pathology*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000235:genetics / Q000473:pathology*; D008830:Microbodies / Q000187:drug effects; D009857:Oncogenes / Q000187:drug effects; D010634:Phenobarbital / Q000633:toxicity; D011230:Precancerous Conditions / Q000139:chemically induced / Q000473:pathology
D000975:Antioxidants; D002273:Carcinogens; D012739:Gonadal Steroid Hormones; D006133:Growth Substances; D010634:Phenobarbital